Learn More


 
MBA Tools
MBA Glossary

 


Bristol Myers Squibb Co. - BMY - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Bristol Myers Squibb Co. - SIC # 2834

Ticker Exchange SIC # Website Latest Ticker
BMY New York 2834 http://www.bms.com/pages/default.aspx 43.92 Stock Up +0.62

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Bristol Myers Squibb Co.

Early Glance: Pharmaceuticals companies - May 20th, 2013 8:33 am
Early Glance: Pharmaceuticals companies - May 20th, 2013 8:33 am
[video] Monday's Market Roadmap - May 20th, 2013 7:01 am
Shades Of 1999 - May 19th, 2013 7:10 pm
1 Giant Leap for MannKind - May 18th, 2013 10:45 am
Oncothyreon A Speculative Buy - May 17th, 2013 6:52 pm
Final Glance: Pharmaceuticals companies - May 17th, 2013 4:03 pm
Final Glance: Pharmaceuticals companies - May 17th, 2013 4:03 pm
Midday Glance: Pharmaceuticals companies - May 17th, 2013 11:33 am
Midday Glance: Pharmaceuticals companies - May 17th, 2013 11:33 am
Analysts' Actions: AMAT ARUN BMY DE WSM - May 17th, 2013 6:53 am
[$$] AbbVie Is Good Medicine - May 16th, 2013 5:15 pm


View All Current Headlines >>

Bookmark and Share
facebooktwitter